Latest Industry Insights

In this interview, we explore the relationship between allergies and mental health, and how advances in diagnostic testing could help clinicians offer more personalized patient care.

Discover insights on the challenges of CTCs and ctDNA from liquid biopsies as cancer diagnostic tools, how novel technology is helping to overcome some of these issues and the future monitoring landscape.

Technology Networks spoke with Stefan Foser, vice president of global pharma at Bruker, to explore how they integrate instrumentation, software and consumables to support early-stage pharma innovation.

From theory to clinic, explore how molecular glue innovation is transforming targeted protein degradation for cancer and other diseases. Offering a new path to degrade targets once thought undruggable.

Explore how multiomics research combines genomics, proteomics, and transcriptomics to offer new insights in disease modeling and therapeutic advancements.

The diagnostics landscape has transformed over the last 12 months. In this interview, Mara Aspinall, a leader in diagnostic innovation, policy and partner at Illumina Ventures, reflected on the defining moments of the last year and what lies ahead.

Weight loss isn’t just cosmetic; it prevents chronic disease, saves money and improves mental and physical well-being. Explore the latest weight loss research and learn how even moderate weight loss can transform metabolic health.

Following the Galien Forum, Technology Networks spoke with Sanket Shah, president of Otsuka Precision Health, to learn how the company is advocating for healthcare change by combining digital innovation with meaningful human connection.

Learn how Bruker’s latest innovations are enhancing small molecule analysis for toxicology and environmental analysis.

In this interview, discover how Astoriom's Integrated Stability & Sustainability Outsourcing Model addresses traditional storage challenges and enables biopharma companies to respond more nimbly to disruptions.